Drug Free Solution Stock Today
| DSOL Stock | USD 0.0002 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 41
|
Drug Free is selling for 2.0E-4 as of the 28th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.0E-4. Drug Free has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Drug Free Solution are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. The company has 35.94 M outstanding shares. More on Drug Free Solution
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Drug Pink Sheet Highlights
| Business Concentration | Health Care, Health Care Providers & Services, Health Information Services, Healthcare (View all Sectors) |
Drug Free Solution [DSOL] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 503.2 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Drug Free's market, we take the total number of its shares issued and multiply it by Drug Free's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Drug Free Solution conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 35.94 M outstanding shares.
Drug Free Solution currently holds about 7.12 K in cash with (692.31 K) of positive cash flow from operations.
Check Drug Free Probability Of Bankruptcy
Drug Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Drug Free without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Drug Free Corporate Executives
Elected by the shareholders, the Drug Free's board of directors comprises two types of representatives: Drug Free inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Drug. The board's role is to monitor Drug Free's management team and ensure that shareholders' interests are well served. Drug Free's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Drug Free's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Genie OMalley | Pres, Founder | Profile |
Other Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.